Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immunotherapy
immunotherapy
Astellas strikes $1.7bn SIRP drug deal with Elpiscience
Pharmaphorum
Tue, 01/2/24 - 09:56 am
Astellas
Elpiscience
immunotherapy
macrophages
Cidara’s J&J-partnered immunotherapy could target flu and cancer
Pharma Voice
Thu, 10/26/23 - 10:35 am
Cidara
JNJ
immunotherapy
drug-Fc conjugates
cancer
Flu
GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer
Fierce Pharma
Mon, 07/31/23 - 09:59 pm
GSK
FDA
immunotherapy
endometrial cancer
Jemperli
Sellas celebrates positive Phase I results in lung cancer
Clinical Trials Arena
Thu, 06/29/23 - 11:35 am
Sellas
clinical trials
immunotherapy
Opdivo
mesothelioma
lung cancer
Prime and Cimeio form research alliance to develop genetic disease solution
Medical Device Network
Fri, 06/23/23 - 09:40 am
Prime Medicine
Cimeio Therapeutics
immunotherapy
genetic diseases
Larkspur Biosciences Launches with $35.5 Million in Financing to Build the Next Precision Immunotherapies to Outsmart Cancer
Globe Newswire
Tue, 05/23/23 - 11:40 am
Larkspur Biosciences
immunotherapy
cancer
funding
Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline
PR Newswire
Thu, 05/18/23 - 10:48 am
Myeloid Therapeutics
funding
MRNA
immunotherapy
With new startup, immunotherapy pioneer Lieping Chen tries to turn ‘cold’ tumors ‘hot’
BioPharma Dive
Tue, 10/25/22 - 11:03 am
Normunity
immunotherapy
oncology
Harvard spinout Surge emerges with $26M to make immunotherapy part of cancer surgery
MedCity News
Fri, 10/21/22 - 10:42 am
Surge Therapeutics
Harvard
immunotherapy
solid tumors
funding
Using Machine Learning to Predict Immunotherapy Response
Medical Devices and Diagnostics Industry
Wed, 07/13/22 - 08:20 pm
machine learning
Medtech
diagnostics
immunotherapy
immune checkpoint inhibitors
artificial intelligence
Appetite for allergies: Alladapt banks $119M to push immunotherapy through trials
Fierce Biotech
Thu, 06/23/22 - 10:43 am
Alladapt Immunotherapeutics
funding
FDA
food allergies
immunotherapy
Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks
Fierce Biotech
Thu, 06/2/22 - 12:19 pm
Bristol Myers Squibb
Immatics
SPAC
immunotherapy
drug discovery
biobucks
Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets
MedCity News
Wed, 04/27/22 - 10:51 am
startups
Pheast Therapeutics
Forty Seven
immunotherapy
Bristol Myers scraps $2B Nektar partnership after trial failures
BioPharma Dive
Mon, 04/18/22 - 11:42 pm
Bristol Myers Squibb
Nektar Therapeutics
immunotherapy
Opdivo
kidney cancer
bladder cancer
BriaCell advances preparatory work for new Bria-OTS™ breast cancer clinical trial
BioSpace
Thu, 04/7/22 - 10:39 am
BriaCell
breast cancer
Bria-OTS
immunotherapy
Intellia follows CRISPR peers with deal to explore 'natural killer' cell therapy
BioPharma Dive
Tue, 02/15/22 - 11:28 pm
Intellia Therapeutics
ONK Therapeutics
natural killer cell therapy
immunotherapy
Bristol Myers returns to Immatics for a dual-targeting cancer drug
BioPharma Dive
Tue, 12/14/21 - 11:10 am
Bristol Myers Squibb
Immatics
cancer
immunotherapy
Vaxxinity, hoping to turn bodies into their own drug factories, makes a subdued Wall Street debut
Fierce Biotech
Thu, 11/11/21 - 11:03 am
Vaxxinity
IPOs
vaccines
immunotherapy
NASDAQ
Biotech Raises $140 Million to Advance iPSC-based Immunotherapies
BioSpace
Tue, 11/2/21 - 11:44 pm
Shoreline Biosciences
pluripotent stem cells
iPSC
immunotherapy
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
MedCity News
Wed, 09/1/21 - 10:54 am
Asher Bio
funding
immunotherapy
cancer immunotherapy
Pages
1
2
3
4
5
6
next ›
last »